The Australian Commission for Safety and Quality in Health Care has invited the College to nominate a representative to contribute to the development of resources and messaging to alert rural and remote medicine practitioners of a sustained increase in community-onset Clostridioides difficile infection (CDI) in Australia since 2016.
 
Information on this issue is important for GPs and their patients because CDI is potentially life-threatening. Early detection of CDI can contribute to reducing the impact for patients; and appropriate antimicrobial prescribing minimises the risk of CDI occurring.
 
The commitment is likely a day in total spread over two meetings of 1-2 hours, and some out of session time reviewing draft resources. The work is expected to commence in November 2022.   

The Commission is able to offer reimbursement to the ACRRM nominee.  

If you are interested in taking on this role, please contact policy@acrrm.org.au; including a recent CV or outline of any relevant qualifications and experience, by Friday, 23 September. Please include reference to the prevention of community-onset Clostridioides difficile infection in the subject line. 

The College acknowledges and thanks member who take on these roles on its behalf.